Busk Morten, Munk Ole L, Jakobsen Steen, Frøkiær Jørgen, Overgaard Jens, Horsman Michael R
a Department of Experimental Clinical Oncology , Aarhus University Hospital , Aarhus , Denmark.
b Department of Nuclear Medicine & PET Center, Aarhus University Hospital , Aarhus , Denmark.
Acta Oncol. 2017 May;56(5):706-712. doi: 10.1080/0284186X.2016.1276620. Epub 2017 Jan 17.
Current [F-18]-fluorodeoxyglucose positron emission tomography (FDG-PET) procedures in tumor-bearing mice typically includes fasting, anesthesia, and standardized uptake value (SUV)-based quantification. Such procedures may be inappropriate for prolonged multiscan experiments. We hypothesize that normalization of tumor FDG retention relative to a suitable reference tissue may improve accuracy as this method may be less susceptible to uncontrollable day-to-day changes in blood glucose levels, physical activity, or unnoticed imperfect tail vein injections.
Fed non-anesthetized tumor-bearing mice were administered FDG intravenously (i.v.) or intraperitoneally (i.p.) and PET scanned on consecutive days using a Mediso nanoScan PET/magnetic resonance imaging (MRI). Reproducibility of various PET-deduced measures of tumor FDG retention, including normalization to FDG signal in reference organs and a conventional SUV approach, was evaluated.
Day-to-day variability in i.v. injected mice was lower when tumor FDG retention was normalized to brain signal (T/B), compared to normalization to other tissues or when using SUV-based normalization. Assessment of tissue radioactivity in dissected tissues confirmed the validity of PET-derived T/B ratios. Mean T/B and SUV values were similar in i.v. and i.p. administered animals, but SUV normalization was more robust in the i.p. group than in the i.v. group.
Multimodality scanners allow tissue delineation and normalization of tumor FDG uptake relative to reference tissues. Normalization to brain, but not liver or kidney, improved scan reproducibility considerably and was superior to traditional SUV quantification in i.v. tracer-injected animals. Day-to-day variability in SUV's was lower in i.p. than in i.v. injected animals, and i.p. injections may therefore be a valuable alternative in prolonged rodent studies, where repeated vein injections are undesirable.
目前在荷瘤小鼠中进行的[F-18]氟脱氧葡萄糖正电子发射断层扫描(FDG-PET)程序通常包括禁食、麻醉以及基于标准化摄取值(SUV)的定量分析。此类程序可能不适用于长时间的多扫描实验。我们推测,将肿瘤FDG滞留量相对于合适的参考组织进行归一化处理可能会提高准确性,因为这种方法可能较不易受到血糖水平、身体活动的日常不可控变化或未注意到的尾静脉注射不完美情况的影响。
给喂食状态下未麻醉的荷瘤小鼠静脉内(i.v.)或腹腔内(i.p.)注射FDG,并使用Mediso nanoScan PET/磁共振成像(MRI)连续几天进行PET扫描。评估了各种PET推导的肿瘤FDG滞留量测量方法的可重复性,包括相对于参考器官的FDG信号进行归一化以及传统的SUV方法。
与相对于其他组织进行归一化或使用基于SUV的归一化相比,当肿瘤FDG滞留量相对于脑信号(T/B)进行归一化时,静脉注射小鼠的每日变异性较低。对解剖组织中的放射性进行评估证实了PET推导的T/B比值的有效性。静脉注射和腹腔注射动物的平均T/B和SUV值相似,但在腹腔注射组中,SUV归一化比静脉注射组更稳定。
多模态扫描仪允许进行组织描绘以及将肿瘤FDG摄取相对于参考组织进行归一化。相对于脑而非肝或肾进行归一化可显著提高扫描的可重复性,并且在静脉注射示踪剂的动物中优于传统的SUV定量分析。腹腔注射动物的SUV每日变异性低于静脉注射动物,因此在长时间的啮齿动物研究中,腹腔注射可能是一种有价值的替代方法,因为在这类研究中重复静脉注射是不可取的。